Results 61 to 70 of about 1,887,445 (277)

Ischemia-Modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia

open access: yes, 2004
Background: Ischemia-modified albumin (IMA) is a new marker of myocardial ischemia, there is concern that IMA concentrations may be affected by ischemia occurring in tissues other than the myocardium.
Gaze, D.C.   +6 more
core   +1 more source

Albumin, prealbumin, and ischemia-modified albumin levels upon serial testing and comparison with healthy controls.

open access: yes, 2022
(a) Albumin levels were significantly lower at baseline compared with levels at follow-up and in healthy controls. (b) Prealbumin was found to be significantly higher at follow-up than in healthy controls.
Sang-Won Lee (193873)   +4 more
core   +1 more source

Self‐Assembling Copolymers Encapsulating Single Endothelial Cells Induce Endogenous ECM Deposition and Vascular Regeneration

open access: yesAdvanced Materials, EarlyView.
This study presents the first demonstration of stable sub‐50‐micron single‐cell GPM vesicles fabricated through the intrinsic self‐assembly of an amphiphilic copolymer. Hierarchical assembly of cell containing GPM vesicles into microspheres enable tunable, sustained cell delivery with immune protection.
Viola B. Morris   +11 more
wiley   +1 more source

Development of Dietary Thiol Antioxidant via Reductive Modification of Whey Protein and Its Application in the Treatment of Ischemic Kidney Injury

open access: yesAntioxidants, 2023
Thiol antioxidants play important roles in cell and body defense against oxidative stress. In body fluid, albumin is the richest source of thiol antioxidants.
Yang Sui   +6 more
doaj   +1 more source

Modulation of miR‐23b Wnt/β‐catenin Axis Strengthens Endothelial Barrier Properties

open access: yesAdvanced Science, EarlyView.
Early blood‐brain barrier (BBB) disruption contributes to stroke and CNS disease pathology. miR‐23b was identified as a regulator of BBB integrity in brain endothelial cells. Inhibition of miR‐23b enhanced barrier‐associated properties, promoted repair‐related signaling, and reduced BBB leakage in experimental stroke models, supporting further ...
Victor Anthony Martinez   +16 more
wiley   +1 more source

Ischemia modified albumin in the differential diagnosis of pleural effusions [PDF]

open access: yesRespiratory Medicine, 2011
The differential diagnosis of pleural effusion often requires invasive procedures. Up to 25 percent of pleural effusions can remain undiagnosed with an unclear pathogenesis. Therefore new biological markers may increase diagnostic yield and provide better understanding of pathogenesis of pleural effusion.
Dikensoy, Oner   +5 more
openaire   +2 more sources

Co‐Delivery of Sustained Release Chondroitinase ABC‐37 With Human iPSC‐Derived Neural Progenitors Promotes Transplant Survival and Functional Recovery in a Rodent Model of Stroke

open access: yesAdvanced Science, EarlyView.
A regenerative strategy for stroke combines human stem cell–derived neural progenitor cells with sustained release of a matrix‐modifying, thermostable chondroitinase ABC‐37 enzyme. In a rat model of stroke, co‐delivery enhanced transplanted cell survival and neuronal differentiation, degraded inhibitory extracellular matrix components, and improved ...
Nitzan Letko Khait   +7 more
wiley   +1 more source

Ischemia modified albumin as laboratory marker of acute [PDF]

open access: yesMedicinski Glasnik, 2009
Daily clinical practice still lacks a marker of acute myocardial ischemia as compared with markers ofmyocardial necrosis. Ischemia modifed albumin (IMA) has recently been proposed as a useful biochemicaltool for detection of ischemia – it is a test which
Goran Miličević   +4 more
doaj  

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

FRI0476 ISCHEMIA MODIFIED ALBUMIN IN OSTEOPOROSIS [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2019
Background Osteoporosis is a common bone metabolism disease, characterized by low bone mass and pathological fractures. This disease is caused by loss of balance in bone resorption and formation. It is thought that this imbalance is associated with increasing in reactive oxygen species (ROS) and/or insufficiency of antioxidant defense (1).
ALISIK Tugba   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy